表紙
市場調查報告書

神經科學研究用抗體的全球市場

Neuroscience Antibodies and Assays

出版商 Global Industry Analysts, Inc. 商品編碼 908509
出版日期 內容資訊 英文 225 Pages
商品交期: 最快1-2個工作天內
價格
神經科學研究用抗體的全球市場 Neuroscience Antibodies and Assays
出版日期: 2020年09月01日內容資訊: 英文 225 Pages
簡介

本報告提供全球神經科學研究用抗體市場調查,提供市場定義和概要,市場趨勢·市場成長的各種影響因素分析,競爭企業與市場佔有率,世界及地區·各主要國家的市場規模的變化與預測,各種區分的明細,主要企業的簡介等系統性資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球競爭企業的市場佔有率
    • 全球競爭企業的市場佔有率:方案
  • 主要企業
  • 市場趨勢·成長推進因素
  • 全球市場的展望
    • 市場規模的估計·預測:各區各國
    • 市場佔有率的轉變
    • 消耗品
    • 設備
    • 醫藥品 & 生物科技企業
    • 大學 & 研究機關
    • 醫院 & 診斷中心
    • 免疫化學/免疫檢測
    • 分子診斷
    • 臨床化學
    • 其他技術

第3章 市場分析

  • 地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲各國
  • 亞太地區
  • 其他 (ROW)

第4章 競爭企業

  • ABCAM PLC
  • BIO-RAD LABORATORIES
  • BIOLEGEND
  • CELL SIGNALING TECHNOLOGY
  • F. HOFFMANN-LA ROCHE AG
  • GENSCRIPT BIOTECH CORPORATION
  • MERCK KGAA
  • ROCKLAND IMMUNOCHEMICALS
  • SANTA CRUZ BIOTECHNOLOGY
  • SIEMENS HEALTHINEERS
  • TECAN GROUP
  • THERMO FISHER SCIENTIFIC

第5章 調查資料

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP13582

Global Neuroscience Antibodies and Assays Market to Reach $5.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Neuroscience Antibodies and Assays estimated at US$2.8 Billion in the year 2020, is projected to reach a revised size of US$5.1 Billion by 2027, growing at aCAGR of 8.8% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 9.2% CAGR and reach US$3.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 7.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $831.1 Million, While China is Forecast to Grow at 8.2% CAGR

The Neuroscience Antibodies and Assays market in the U.S. is estimated at US$831.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$879.3 Million by the year 2027 trailing a CAGR of 8.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.3% and 7.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR.We bring years of research experience to this 9th edition of our report. The 225-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abcam PLC
  • BioLegend, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • F. Hoffmann-La Roche AG
  • GenScript Biotech Corporation
  • Merck KgaA
  • Rockland Immunochemicals, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Siemens Healthineers
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Competitor Market Shares
    • Neuroscience Antibodies and Assays Competitor Market Share Scenario Worldwide (in %): 2019 &
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: Neuroscience Antibodies and Assays Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 2: Neuroscience Antibodies and Assays Global Retrospective Market Scenario in US$ Million by Region/Country: 2012
    • TABLE 3: Neuroscience Antibodies and Assays Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS
    • TABLE 4: Consumables (Product) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 5: Consumables (Product) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 6: Consumables (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 7: Instruments (Product) Potential Growth Markets Worldwide in US$ Million: 2020 to
    • TABLE 8: Instruments (Product) Historic Market Perspective by Region/Country in US$ Million: 2012 to
    • TABLE 9: Instruments (Product) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS
    • TABLE 10: Immunochemistry/Immunoassays (Technology) Geographic Market Spread Worldwide in US$ Million: 2020 to
    • TABLE 11: Immunochemistry/Immunoassays (Technology) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to
    • TABLE 12: Immunochemistry/Immunoassays (Technology) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 13: Molecular Diagnostics (Technology) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to
    • TABLE 14: Molecular Diagnostics (Technology) Market Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 15: Molecular Diagnostics (Technology) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 16: Clinical Chemistry (Technology) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 17: Clinical Chemistry (Technology) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 18: Clinical Chemistry (Technology) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 19: Other Technologies (Technology) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to
    • TABLE 20: Other Technologies (Technology) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 21: Other Technologies (Technology) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS
    • TABLE 22: Pharmaceutical & Biotechnology Companies (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2020
    • TABLE 23: Pharmaceutical & Biotechnology Companies (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2012
    • TABLE 24: Pharmaceutical & Biotechnology Companies (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 25: Academic & Research Institutes (End-Use) Worldwide Sales in US$ Million by Region/Country: 2020
    • TABLE 26: Academic & Research Institutes (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2012
    • TABLE 27: Academic & Research Institutes (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS
    • TABLE 28: Hospitals & Diagnostic Centers (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020
    • TABLE 29: Hospitals & Diagnostic Centers (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2012
    • TABLE 30: Hospitals & Diagnostic Centers (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Neuroscience Antibodies and Assays Market Share (in %) by Company: 2019 &
    • Market Analytics
    • TABLE 31: United States Neuroscience Antibodies and Assays Market Estimates and Projections in US$ Million by Product: 2020 to
    • TABLE 32: Neuroscience Antibodies and Assays Market in the United States by Product: A Historic Review in US$ Million for 2012
    • TABLE 33: United States Neuroscience Antibodies and Assays Market Share Breakdown by Product: 2012 VS 2020 VS
    • TABLE 34: Neuroscience Antibodies and Assays Market in US$ Million in the United States by Technology: 2020
    • TABLE 35: United States Neuroscience Antibodies and Assays Market Retrospective Analysis in US$ Million by Technology: 2012
    • TABLE 36: United States Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 37: United States Neuroscience Antibodies and Assays Latent Demand Forecasts in US$ Million by End-Use: 2020 to
    • TABLE 38: Neuroscience Antibodies and Assays Historic Demand Patterns in the United States by End-Use in US$ Million for 2012
    • TABLE 39: Neuroscience Antibodies and Assays Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS
  • CANADA
    • TABLE 40: Canadian Neuroscience Antibodies and Assays Market Estimates and Forecasts in US$ Million by Product: 2020 to
    • TABLE 41: Canadian Neuroscience Antibodies and Assays Historic Market Review by Product in US$ Million: 2012
    • TABLE 42: Neuroscience Antibodies and Assays Market in Canada: Percentage Share Breakdown of Sales by Product for 2012, 2020, and
    • TABLE 43: Neuroscience Antibodies and Assays Market Analysis in Canada in US$ Million by Technology: 2020
    • TABLE 44: Neuroscience Antibodies and Assays Market in Canada: Historic Review in US$ Million by Technology for the Period 2012
    • TABLE 45: Canadian Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 46: Canadian Neuroscience Antibodies and Assays Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
    • TABLE 47: Neuroscience Antibodies and Assays Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012
    • TABLE 48: Canadian Neuroscience Antibodies and Assays Market Share Analysis by End-Use: 2012 VS 2020 VS
  • JAPAN
    • TABLE 49: Japanese Market for Neuroscience Antibodies and Assays: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2020
    • TABLE 50: Neuroscience Antibodies and Assays Market in Japan: Historic Sales Analysis in US$ Million by Product for the Period 2012
    • TABLE 51: Japanese Neuroscience Antibodies and Assays Market Share Analysis by Product: 2012 VS 2020 VS
    • TABLE 52: Japanese Medium & Long-Term Outlook for Neuroscience Antibodies and Assays Market in US$ Million by Technology: 2020
    • TABLE 53: Neuroscience Antibodies and Assays Market in Japan in US$ Million by Technology: 2012
    • TABLE 54: Japanese Neuroscience Antibodies and Assays Market Percentage Share Distribution by Technology: 2012 VS 2020 VS
    • TABLE 55: Japanese Demand Estimates and Forecasts for Neuroscience Antibodies and Assays in US$ Million by End-Use: 2020 to
    • TABLE 56: Japanese Neuroscience Antibodies and Assays Market in US$ Million by End-Use: 2012
    • TABLE 57: Neuroscience Antibodies and Assays Market Share Shift in Japan by End-Use: 2012 VS 2020 VS
  • CHINA
    • TABLE 58: Chinese Neuroscience Antibodies and Assays Market Growth Prospects in US$ Million by Product for the Period 2020
    • TABLE 59: Neuroscience Antibodies and Assays Historic Market Analysis in China in US$ Million by Product: 2012
    • TABLE 60: Chinese Neuroscience Antibodies and Assays Market by Product: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 61: Neuroscience Antibodies and Assays Market Estimates and Forecasts in China in US$ Million by Technology: 2020
    • TABLE 62: Chinese Neuroscience Antibodies and Assays Retrospective Market Scenario in US$ Million by Technology: 2012
    • TABLE 63: Neuroscience Antibodies and Assays Market in China: Percentage Share Analysis by Technology for 2012, 2020, and
    • TABLE 64: Chinese Demand for Neuroscience Antibodies and Assays in US$ Million by End-Use: 2020 to
    • TABLE 65: Neuroscience Antibodies and Assays Market Review in China in US$ Million by End-Use: 2012
    • TABLE 66: Chinese Neuroscience Antibodies and Assays Market Share Breakdown by End-Use: 2012 VS 2020 VS
  • EUROPE
    • Market Facts & Figures
    • European Neuroscience Antibodies and Assays Market: Competitor Market Share Scenario (in %) for 2019 &
    • Market Analytics
    • TABLE 67: European Neuroscience Antibodies and Assays Market Demand Scenario in US$ Million by Region/Country: 2020
    • TABLE 68: Neuroscience Antibodies and Assays Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012
    • TABLE 69: European Neuroscience Antibodies and Assays Market Share Shift by Region/Country: 2012 VS 2020 VS
    • TABLE 70: European Neuroscience Antibodies and Assays Market Estimates and Forecasts in US$ Million by Product: 2020
    • TABLE 71: Neuroscience Antibodies and Assays Market in Europe in US$ Million by Product: A Historic Review for the Period 2012
    • TABLE 72: European Neuroscience Antibodies and Assays Market Share Breakdown by Product: 2012 VS 2020 VS
    • TABLE 73: European Neuroscience Antibodies and Assays Market Assessment in US$ Million by Technology: 2020
    • TABLE 74: European Neuroscience Antibodies and Assays Historic Market Review in US$ Million by Technology: 2012
    • TABLE 75: Neuroscience Antibodies and Assays Market in Europe: Percentage Breakdown of Sales by Technology for 2012, 2020, and
    • TABLE 76: European Neuroscience Antibodies and Assays Addressable Market Opportunity in US$ Million by End-Use: 2020
    • TABLE 77: Neuroscience Antibodies and Assays Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012
    • TABLE 78: European Neuroscience Antibodies and Assays Market Share Analysis by End-Use: 2012 VS 2020 VS
  • FRANCE
    • TABLE 79: Neuroscience Antibodies and Assays Market in France by Product: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 80: French Neuroscience Antibodies and Assays Historic Market Scenario in US$ Million by Product: 2012
    • TABLE 81: French Neuroscience Antibodies and Assays Market Share Analysis by Product: 2012 VS 2020 VS
    • TABLE 82: French Neuroscience Antibodies and Assays Market Estimates and Projections in US$ Million by Technology: 2020
    • TABLE 83: French Neuroscience Antibodies and Assays Historic Market Analysis in US$ Million by Technology: 2012
    • TABLE 84: French Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 85: Neuroscience Antibodies and Assays Quantitative Demand Analysis in France in US$ Million by End-Use: 2020
    • TABLE 86: French Neuroscience Antibodies and Assays Historic Market Review in US$ Million by End-Use: 2012
    • TABLE 87: French Neuroscience Antibodies and Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
  • GERMANY
    • TABLE 88: Neuroscience Antibodies and Assays Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2020
    • TABLE 89: German Neuroscience Antibodies and Assays Historic Market Analysis in US$ Million by Product: 2012
    • TABLE 90: German Neuroscience Antibodies and Assays Market Share Breakdown by Product: 2012 VS 2020 VS
    • TABLE 91: German Neuroscience Antibodies and Assays Latent Demand Forecasts in US$ Million by Technology: 2020
    • TABLE 92: Neuroscience Antibodies and Assays Market in Germany: A Historic Perspective by Technology in US$ Million for the Period 2012
    • TABLE 93: German Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 94: Neuroscience Antibodies and Assays Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020
    • TABLE 95: German Neuroscience Antibodies and Assays Market in Retrospect in US$ Million by End-Use: 2012
    • TABLE 96: Neuroscience Antibodies and Assays Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS
  • ITALY
    • TABLE 97: Italian Neuroscience Antibodies and Assays Market Growth Prospects in US$ Million by Product for the Period 2020
    • TABLE 98: Neuroscience Antibodies and Assays Historic Market Analysis in Italy in US$ Million by Product: 2012
    • TABLE 99: Italian Neuroscience Antibodies and Assays Market by Product: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 100: Neuroscience Antibodies and Assays Market Estimates and Forecasts in Italy in US$ Million by Technology: 2020
    • TABLE 101: Italian Neuroscience Antibodies and Assays Retrospective Market Scenario in US$ Million by Technology: 2012
    • TABLE 102: Neuroscience Antibodies and Assays Market in Italy: Percentage Share Analysis by Technology for 2012, 2020, and
    • TABLE 103: Italian Demand for Neuroscience Antibodies and Assays in US$ Million by End-Use: 2020 to
    • TABLE 104: Neuroscience Antibodies and Assays Market Review in Italy in US$ Million by End-Use: 2012
    • TABLE 105: Italian Neuroscience Antibodies and Assays Market Share Breakdown by End-Use: 2012 VS 2020 VS
  • UNITED KINGDOM
    • TABLE 106: United Kingdom Market for Neuroscience Antibodies and Assays: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2020
    • TABLE 107: Neuroscience Antibodies and Assays Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product for the Period 2012
    • TABLE 108: United Kingdom Neuroscience Antibodies and Assays Market Share Analysis by Product: 2012 VS 2020 VS
    • TABLE 109: United Kingdom Medium & Long-Term Outlook for Neuroscience Antibodies and Assays Market in US$ Million by Technology: 2020
    • TABLE 110: Neuroscience Antibodies and Assays Market in the United Kingdom in US$ Million by Technology: 2012
    • TABLE 111: United Kingdom Neuroscience Antibodies and Assays Market Percentage Share Distribution by Technology: 2012 VS 2020 VS
    • TABLE 112: United Kingdom Demand Estimates and Forecasts for Neuroscience Antibodies and Assays in US$ Million by End-Use: 2020 to
    • TABLE 113: United Kingdom Neuroscience Antibodies and Assays Market in US$ Million by End-Use: 2012
    • TABLE 114: Neuroscience Antibodies and Assays Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS
  • REST OF EUROPE
    • TABLE 115: Rest of Europe Neuroscience Antibodies and Assays Market Estimates and Forecasts in US$ Million by Product: 2020
    • TABLE 116: Neuroscience Antibodies and Assays Market in Rest of Europe in US$ Million by Product: A Historic Review for the Period 2012
    • TABLE 117: Rest of Europe Neuroscience Antibodies and Assays Market Share Breakdown by Product: 2012 VS 2020 VS
    • TABLE 118: Rest of Europe Neuroscience Antibodies and Assays Market Assessment in US$ Million by Technology: 2020
    • TABLE 119: Rest of Europe Neuroscience Antibodies and Assays Historic Market Review in US$ Million by Technology: 2012
    • TABLE 120: Neuroscience Antibodies and Assays Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2012, 2020, and
    • TABLE 121: Rest of Europe Neuroscience Antibodies and Assays Addressable Market Opportunity in US$ Million by End-Use: 2020
    • TABLE 122: Neuroscience Antibodies and Assays Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012
    • TABLE 123: Rest of Europe Neuroscience Antibodies and Assays Market Share Analysis by End-Use: 2012 VS 2020 VS
  • ASIA-PACIFIC
    • TABLE 124: Neuroscience Antibodies and Assays Market in Asia-Pacific by Product: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 125: Asia-Pacific Neuroscience Antibodies and Assays Historic Market Scenario in US$ Million by Product: 2012
    • TABLE 126: Asia-Pacific Neuroscience Antibodies and Assays Market Share Analysis by Product: 2012 VS 2020 VS
    • TABLE 127: Asia-Pacific Neuroscience Antibodies and Assays Market Estimates and Projections in US$ Million by Technology: 2020
    • TABLE 128: Asia-Pacific Neuroscience Antibodies and Assays Historic Market Analysis in US$ Million by Technology: 2012
    • TABLE 129: Asia-Pacific Neuroscience Antibodies and Assays Historic Market Analysis in US$ Million by Technology: 2012 VS 2020 VS
    • TABLE 130: Neuroscience Antibodies and Assays Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020
    • TABLE 131: Asia-Pacific Neuroscience Antibodies and Assays Historic Market Review in US$ Million by End-Use: 2012
    • TABLE 132: Asia-Pacific Neuroscience Antibodies and Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
  • REST OF WORLD
    • TABLE 133: Rest of World Neuroscience Antibodies and Assays Market Estimates and Forecasts in US$ Million by Product: 2020 to
    • TABLE 134: Rest of World Neuroscience Antibodies and Assays Historic Market Review by Product in US$ Million: 2012
    • TABLE 135: Neuroscience Antibodies and Assays Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2012, 2020, and
    • TABLE 136: Neuroscience Antibodies and Assays Market Analysis in Rest of World in US$ Million by Technology: 2020
    • TABLE 137: Neuroscience Antibodies and Assays Market in Rest of World: Historic Review in US$ Million by Technology for the Period 2012
    • TABLE 138: Rest of World Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 139: Rest of World Neuroscience Antibodies and Assays Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
    • TABLE 140: Neuroscience Antibodies and Assays Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012
    • TABLE 141: Rest of World Neuroscience Antibodies and Assays Market Share Analysis by End-Use: 2012 VS 2020 VS

IV. COMPETITION

  • Total Companies Profiled: 42